Sunday, February 22, 2026
21.9 C
Bengaluru

Creat Customer

MedicinMan September 2015

[wpfilebase tag=file id=51 tpl=download-button /]

Inside this Issue

1. Leading with Purpose by K. Hariram

Pharma managers must lead their team with a clear purpose – to make work meaningful.

2. Healthcare and the Freedom of Choice by Salil Kallianpur

Patients should be free to choose their healthcare provider rather than be dependent on the government. Only then will the cost of healthcare come down and the efficiency of the system increase.

3. Patient Access Part-I: A Conceptual Overview by Pankaj Mehrotra

In a highly fragmented yet alluring healthcare market one of the ways to survive and thrive is to increase patient access.

4. How to Communicate Your Incentive Compensation Plan by Amit Jain

Once you have designed an incentive compensation plan for your salesforce, how effectively you communicate it will determine the buy-in and eventual success of the plan.

5. Effective Pre-Call Planning Using Predictive Analytics by Dr. Palakodeti Ratnakar

Analytics and mobile can make the pre-call planning process dynamic and greatly increase the ROI of a call.

6. BOOK REVIEW: ‘Targetitis: the Current Organizational Disease’ by Vivek Hattangadi

A mindless drive to set targets and measure achievement can be detrimental to the health of the field force!

7. Medical Rep or Sales Person? by Hanno Wolfram

Purely economic considerations have reduced the role of the Medical Rep from scientific partner to the Doctor to a mere salesperson. How can this be amended?

Hot this week

India’s Pharma Renaissance: Private Equity at the Helm

Indian pharmaceuticals have long been known as the “pharmacy...

The ₹5 Snack SKU: A Silent Indian Metabolic Crisis

Executive Summary — The Paradox of Scale In the annals...

Sleep Apnea: Apnimed Pill to Replace CPAP Machine?

In India, where urban sleep debt is rising, obesity...

Why the World Still Doesn’t Celebrate Antibiotic Breakthroughs llike Zaynich

When a new cancer drug shows promise, it trends...

From Overuse to Overreaction: Recalibrating India’s C-Section Debate

India’s caesarean section debate is drifting toward polarisation. On one...

Topics

India’s Pharma Renaissance: Private Equity at the Helm

Indian pharmaceuticals have long been known as the “pharmacy...

The ₹5 Snack SKU: A Silent Indian Metabolic Crisis

Executive Summary — The Paradox of Scale In the annals...

Sleep Apnea: Apnimed Pill to Replace CPAP Machine?

In India, where urban sleep debt is rising, obesity...

From Overuse to Overreaction: Recalibrating India’s C-Section Debate

India’s caesarean section debate is drifting toward polarisation. On one...

Sanofi’s Decision not to Renew Paul Hudson as CEO Marks a Structural Shift

In big pharma, leadership changes are rarely impulsive. They...

THE ENCUBE ETHICALS PLAYBOOK: FROM GOA WORKSHOP TO $2BN+ GLOBAL DEAL

How a niche Indian topicals manufacturer outgrew its CDMO...

Indian Pharma: Are Regulatory Gaps From Generics Following Biosimilars?

Transparency, Trust, and the Problem of “Invisible Evidence” in...
spot_img

Related Articles

spot_imgspot_img